Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Airsculpt Technologies Inc

Healthcare US AIRS

4.74USD
-0.2(4.05%)

Last update at 2026-06-22T20:25:00Z

Day Range

4.564.88
LowHigh

52 Week Range

1.5112.00
LowHigh

Fundamentals

  • Previous Close 4.94
  • Market Cap186.24M
  • Volume523423
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA7.95M
  • Revenue TTM151.82M
  • Revenue Per Share TTM2.51
  • Gross Profit TTM 100.13M
  • Diluted EPS TTM-0.19

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -17.63800M -8.06300M 3.00M -11.29600M 10.88M
Minority interest - - - - -
Net income -11.66700M -8.25100M -4.47900M -14.67900M 10.55M
Selling general administrative 82.18M 72.18M 82.38M 101.42M 65.73M
Selling and marketing expenses - 33.40M 25.90M - -
Gross profit 90.13M 108.97M 121.91M 106.01M 88.78M
Reconciled depreciation 12.78M 11.89M 9.70M 8.06M 6.60M
Ebit -11.56000M -1.81600M 9.48M -3.46600M 15.77M
Ebitda 1.22M 10.07M 19.74M 4.59M 23.05M
Depreciation and amortization 12.78M 11.89M 10.25M 8.06M 7.28M
Non operating income net other - - - - -
Operating income -4.83300M -1.81600M 9.48M -3.46600M 15.77M
Other operating expenses 156.65M 182.17M 186.43M 172.26M 116.86M
Interest expense 6.08M 6.25M 6.49M 6.75M 4.89M
Tax provision -5.97100M 0.19M 1.82M 3.38M 0.33M
Interest income - - - - -
Net interest income -6.07800M -6.24700M -7.39200M -6.75100M -4.88800M
Extraordinary items - - - - -
Non recurring - - - 0.15M -
Other items - - - - -
Income tax expense -5.97100M 0.19M 7.48M 3.38M 0.33M
Total revenue 151.82M 180.35M 195.92M 168.79M 133.31M
Total operating expenses 94.96M 110.78M 112.42M 109.48M 72.33M
Cost of revenue 61.69M 71.38M 74.01M 62.78M 44.54M
Total other income expense net -12.80500M -6.24700M -6.48500M -7.83000M -4.88800M
Discontinued operations - - - - -
Net income from continuing ops -11.66700M -8.25100M -7.09700M -14.67900M 10.55M
Net income applicable to common shares - - - -14.67900M 10.55M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 187.30M 210.00M 213.55M 200.76M 200.55M
Intangible assets 36.84M 41.59M 46.35M 51.10M 55.85M
Earning assets - - - - -
Other current assets 5.51M 5.83M 3.76M 4.23M 4.09M
Total liab 99.59M 130.71M 129.56M 129.99M 117.03M
Total stockholder equity 87.71M 79.29M 83.99M 70.77M 83.53M
Deferred long term liab - - - 5.49M 4.35M
Other current liab 7.91M 10.84M 7.43M 9.63M 6.61M
Common stock 0.06M 0.06M 0.06M 0.06M 0.06M
Capital stock 0.06M 0.06M 0.06M 0.06M 0.06M
Retained earnings -40.57100M -27.80200M -19.55100M -15.07200M -0.39300M
Other liab - - - 6.51M 18.86M
Good will 81.73M 81.73M 81.73M 81.73M 81.73M
Other assets - - 0.00000M 3.28M 171.11M
Cash 8.45M 8.23M 10.26M 9.62M 25.35M
Cash and equivalents - - - - -
Total current liabilities 27.90M 28.61M 20.32M 22.32M 16.41M
Current deferred revenue 1.87M 1.17M 1.46M 2.36M 2.81M
Net debt 75.12M 96.82M 89.41M 98.03M 75.24M
Short term debt 12.76M 10.35M 7.50M 6.48M 4.32M
Short long term debt 5.46M 4.25M 2.12M 2.12M 0.85M
Short long term debt total 83.57M 105.05M 99.67M 107.65M 100.58M
Other stockholder equity 128.31M 107.72M 103.90M 85.86M 83.86M
Property plant equipment - - - 24.21M 13.63M
Total current assets 15.46M 17.12M 15.96M 16.68M 29.44M
Long term investments - - - - -
Net tangible assets - - - 70.77M 83.53M
Short term investments - - - - -
Net receivables 1.50M 3.06M 1.94M 2.83M 1.74M
Long term debt 50.59M 70.46M 69.50M 81.42M 81.75M
Inventory - - - - -
Accounts payable 5.37M 6.26M 3.92M 3.84M 2.67M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.09600M -0.68700M -0.41200M -0.07600M -
Additional paid in capital - - - - -
Common stock total equity - - - 0.06M 0.06M
Preferred stock total equity - - - - -
Retained earnings total equity - - - -15.07200M -0.39300M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 3.01M 6.41M 5.66M 3.28M 1.74M
Deferred long term asset charges - - - - -
Non current assets total 171.85M 192.88M 197.59M 184.08M 171.11M
Capital lease obligations 27.52M 30.35M 28.04M 24.10M 17.98M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -14.00700M -10.28700M -12.92100M -7.11600M
Change to liabilities - - - 9.04M 6.34M
Total cashflows from investing activities -2.40400M -14.00700M -9.91900M -12.92100M -7.11600M
Net borrowings -18.79300M 2.88M -12.12500M -0.76000M 48.77M
Total cash from financing activities -0.47800M 0.63M -13.39100M -27.25700M -4.54900M
Change to operating activities - - - 0.89M -0.38200M
Net income -11.66700M -8.25100M -4.47900M -14.67900M 10.55M
Change in cash 0.21M -2.02700M 0.65M -15.73100M 14.97M
Begin period cash flow 8.23M 10.26M 9.62M 25.35M 10.38M
End period cash flow 8.45M 8.23M 10.26M 9.62M 25.35M
Total cash from operating activities 3.10M 11.35M 23.96M 24.45M 26.63M
Issuance of capital stock 18.76M 0.00000M 0.00000M 0.00000M 13.54M
Depreciation 12.78M 11.89M 10.25M 8.06M 6.60M
Other cashflows from investing activities - - - - -
Dividends paid 0.00000M 0.25M 0.46M 24.32M 66.86M
Change to inventory - - - - -
Change to account receivables 1.56M -1.11500M 0.89M - -
Sale purchase of stock - -0.90300M -0.23300M - 13.54M
Other cashflows from financing activities -0.05600M -1.09000M -0.56900M 81.33M 49.60M
Change to netincome - - - 31.67M 8.07M
Capital expenditures 2.40M 14.01M 9.92M 12.92M 7.12M
Change receivables - - - - -
Cash flows other operating - - - -10.56200M -5.57300M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - -15.73100M 14.97M
Change in working capital -1.68700M 3.85M -1.37900M -1.52600M 0.77M
Stock based compensation 2.33M 3.76M 18.22M 29.46M 7.18M
Other non cash items 7.25M 0.35M -0.00500M 2.00M 1.32M
Free cash flow 0.69M -2.65700M 14.04M 11.53M 19.52M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AIRS
Airsculpt Technologies Inc		 -0.2 4.05% 4.74 - - 1.23 2.12 1.72 214.06
HCA
HCA Healthcare, Inc.		 1.82 0.49% 376.99 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.03 0.27% 11.30 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 - -% 5.33 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc		 - -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

Airsculpt Technologies Inc

1111 Lincoln Road, Miami Beach, FL, United States, 33139

Key Executives

Name Title Year Born
Dr. Aaron J. Rollins M.D. Founder, CEO & Director 1976
Mr. Ronald Paul Zelhof COO & Pres 1964
Mr. Dennis Dean Chief Financial Officer 1972
Ms. Liraz Isaac Head of People NA
Dr. Aaron J. Rollins M.D. Founder & Executive Chairman 1976
Mr. Todd Magazine CEO, President & Director 1964
Stephanie Evans Greene Chief Marketing Officer NA
Mr. Yogesh Jashnani CEO & Director 1982
Mr. Michael J. Arthur Chief Financial Officer 1988
Mr. Brent R. Wadman J.D. General Counsel 1972

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.